Cargando…
Discounting in Economic Evaluations
Appropriate discounting rules in economic evaluations have received considerable attention in the literature and in national guidelines for economic evaluations. Rightfully so, as discounting can be quite influential on the outcomes of economic evaluations. The most prominent controversies regarding...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999124/ https://www.ncbi.nlm.nih.gov/pubmed/29779120 http://dx.doi.org/10.1007/s40273-018-0672-z |
_version_ | 1783331365902614528 |
---|---|
author | Attema, Arthur E. Brouwer, Werner B. F. Claxton, Karl |
author_facet | Attema, Arthur E. Brouwer, Werner B. F. Claxton, Karl |
author_sort | Attema, Arthur E. |
collection | PubMed |
description | Appropriate discounting rules in economic evaluations have received considerable attention in the literature and in national guidelines for economic evaluations. Rightfully so, as discounting can be quite influential on the outcomes of economic evaluations. The most prominent controversies regarding discounting involve the basis for and height of the discount rate, whether costs and effects should be discounted at the same rate, and whether discount rates should decline or stay constant over time. Moreover, the choice for discount rules depends on the decision context one adopts as the most relevant. In this article, we review these issues and debates, and describe and discuss the current discounting recommendations of the countries publishing their national guidelines. We finish the article by proposing a research agenda. |
format | Online Article Text |
id | pubmed-5999124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-59991242018-06-28 Discounting in Economic Evaluations Attema, Arthur E. Brouwer, Werner B. F. Claxton, Karl Pharmacoeconomics Review Article Appropriate discounting rules in economic evaluations have received considerable attention in the literature and in national guidelines for economic evaluations. Rightfully so, as discounting can be quite influential on the outcomes of economic evaluations. The most prominent controversies regarding discounting involve the basis for and height of the discount rate, whether costs and effects should be discounted at the same rate, and whether discount rates should decline or stay constant over time. Moreover, the choice for discount rules depends on the decision context one adopts as the most relevant. In this article, we review these issues and debates, and describe and discuss the current discounting recommendations of the countries publishing their national guidelines. We finish the article by proposing a research agenda. Springer International Publishing 2018-05-19 2018 /pmc/articles/PMC5999124/ /pubmed/29779120 http://dx.doi.org/10.1007/s40273-018-0672-z Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Article Attema, Arthur E. Brouwer, Werner B. F. Claxton, Karl Discounting in Economic Evaluations |
title | Discounting in Economic Evaluations |
title_full | Discounting in Economic Evaluations |
title_fullStr | Discounting in Economic Evaluations |
title_full_unstemmed | Discounting in Economic Evaluations |
title_short | Discounting in Economic Evaluations |
title_sort | discounting in economic evaluations |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999124/ https://www.ncbi.nlm.nih.gov/pubmed/29779120 http://dx.doi.org/10.1007/s40273-018-0672-z |
work_keys_str_mv | AT attemaarthure discountingineconomicevaluations AT brouwerwernerbf discountingineconomicevaluations AT claxtonkarl discountingineconomicevaluations |